Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Davis Bhagat,1 Breanne Kirby,1 Harit Bhatt,1,2 Rama Jager,1,2 Meena George,1,2 Veeral Sheth1,2 1University Retina and Macula Associates, Oak Forest, IL, USA; 2University of Illinois, Chicago, IL, USACorrespondence: Veeral ShethUniversity Retina and Macula Associates, 15947 W 127th St Suite E, Lemont...
Main Authors: | Bhagat D, Kirby B, Bhatt H, Jager R, George M, Sheth V |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/patient-preferences-associated-with-anti-vascular-endothelial-growth-f-peer-reviewed-article-OPTH |
Similar Items
-
Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
by: Pengxiang Zhou, et al.
Published: (2021-10-01) -
Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization
by: Müge Çoban Karataş, et al.
Published: (2022-02-01) -
Anti-vascular endothelial growth factor treatment in diabetic macular edema
by: Kim M
Published: (2016-09-01) -
Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01) -
Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration
by: Pelin Kıyat, et al.
Published: (2021-06-01)